Germany Prostate Cancer Diagnostic and Therapeutic Market to Signify Strong Growth by 2019-2025
Germany prostate cancer market is forecast to grow at a CAGR of 11.5% during the forecast period. The high prevalence of prostate cancer in the country is one of the major factors for the demand for prostate cancer diagnostics services and therapeutics. As per the World Health Organization, around 63,000 new cases of prostate cancer were registered in 2018. Cancer has the highest share of all cancer among men in the country with around 19% of the overall cases. The 5-year prevalence in the country due to prostate cancer is around 233,000 in 2018.
(Get 25% Discount on Buying this Report)
To Request a Sample of our Report on Germany
Prostate Cancer Diagnostic and Therapeutic Market: https://www.omrglobal.com/request-sample/germany-prostate-cancer-diagnostic-therapeutic-market
Moreover, the increasing geriatric population, the presence
of highly specialized urologists for prostate cancer treatment are contributing
to the growth of the market. Around 90% of the German population is insured by
the statutory health insurance (SHI). Regardless of the type of health
insurance, all beneficiaries have access to an outpatient physician and
non-physician services, hospital care, rehabilitation, dental care,
prescription drugs, medical supplies and long-term nursing care.
The presence of renowned clinics and treatment centers in
the country is another major factor for the growth of the market as it is
augmenting medical tourism. Martini Klinik is one of the largest prostate
cancer clinics all across the globe that caters to more than 5,000 outpatient
cases and 2,400 surgical cases seen every year. The presence of highly skilled
doctors and urologists in Germany attracts many patients to the country for
receiving treatment procedures. For instance, each surgeon at Martini Klinik
conducts between 200 and 300 procedures per year.
A
full Report of Germany Prostate Cancer Diagnostic and Therapeutic Market is
Available @ https://www.omrglobal.com/industry-reports/germany-prostate-cancer-diagnostic-therapeutic-market
Germany Prostate Cancer Diagnostic and Therapeutic Market
Segmentation
By Diagnostic Techniques
·
Prostate-Specific Antigen Test (PSA)
·
Digital Rectal Examination
·
Prostate Biopsy
·
Imaging Techniques
By Therapeutics
·
Hormonal Therapy
·
Chemotherapy
·
Immunotherapy
·
Radiation Therapy
·
Targeted Therapy
·
Surgery
Company Profiles
·
Abbott Laboratories
·
AbbVie Products, LLC
·
Amgen Inc.
·
AstraZeneca PLC
·
Bavarian Nordic A/S
·
Bayer AG
·
Bristol-Myers Squibb Co.
·
Ferring Pharmaceuticals Inc.
·
GlaxoSmithKline PLC
·
Johnson & Johnson
·
Pfizer Inc.
·
Siemens Healthcare AG
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment